Innospec Inc. (NASDAQ:IOSP) Shares Purchased by Vanguard Group Inc.

Vanguard Group Inc. increased its stake in shares of Innospec Inc. (NASDAQ:IOSP) by 0.2% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 2,576,155 shares of the specialty chemicals company’s stock after acquiring an additional 4,673 shares during the period. Vanguard Group Inc. owned approximately 0.11% of Innospec worth $235,048,000 at the end of the most recent reporting period.

A number of other institutional investors also recently added to or reduced their stakes in the stock. BlackRock Inc. lifted its position in Innospec by 3.6% during the 1st quarter. BlackRock Inc. now owns 4,135,907 shares of the specialty chemicals company’s stock worth $344,728,000 after acquiring an additional 142,191 shares in the last quarter. Wells Fargo & Company MN lifted its position in Innospec by 3.3% during the 2nd quarter. Wells Fargo & Company MN now owns 1,220,629 shares of the specialty chemicals company’s stock worth $111,370,000 after acquiring an additional 38,961 shares in the last quarter. Champlain Investment Partners LLC lifted its position in Innospec by 2.1% during the 1st quarter. Champlain Investment Partners LLC now owns 927,470 shares of the specialty chemicals company’s stock worth $77,305,000 after acquiring an additional 18,840 shares in the last quarter. Northern Trust Corp lifted its position in Innospec by 7.6% during the 2nd quarter. Northern Trust Corp now owns 556,229 shares of the specialty chemicals company’s stock worth $50,751,000 after acquiring an additional 39,519 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its position in Innospec by 103.1% during the 2nd quarter. Janus Henderson Group PLC now owns 420,997 shares of the specialty chemicals company’s stock worth $38,412,000 after acquiring an additional 213,673 shares in the last quarter. 93.24% of the stock is currently owned by hedge funds and other institutional investors.

In other Innospec news, VP Brian Watt sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, August 22nd. The stock was sold at an average price of $84.16, for a total value of $252,480.00. Following the transaction, the vice president now directly owns 27,888 shares of the company’s stock, valued at approximately $2,347,054.08. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 1.62% of the company’s stock.

Shares of IOSP traded down $0.30 during trading on Thursday, reaching $87.02. The company’s stock had a trading volume of 3,100 shares, compared to its average volume of 138,469. The company has a fifty day moving average of $87.59 and a two-hundred day moving average of $86.57. Innospec Inc. has a twelve month low of $53.07 and a twelve month high of $97.18. The company has a market cap of $2.18 billion, a price-to-earnings ratio of 18.04 and a beta of 1.29. The company has a quick ratio of 1.32, a current ratio of 2.14 and a debt-to-equity ratio of 0.19.

Innospec (NASDAQ:IOSP) last announced its earnings results on Tuesday, August 6th. The specialty chemicals company reported $1.12 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.10 by $0.02. Innospec had a return on equity of 15.11% and a net margin of 6.10%. The company had revenue of $362.40 million for the quarter, compared to analyst estimates of $371.20 million. During the same period in the prior year, the company posted $0.80 EPS. Innospec’s quarterly revenue was up 1.2% on a year-over-year basis.

IOSP has been the topic of several recent research reports. Zacks Investment Research lowered Innospec from a “buy” rating to a “hold” rating in a research report on Saturday, July 13th. CL King initiated coverage on Innospec in a research report on Wednesday, September 4th. They issued a “buy” rating and a $95.00 target price on the stock. BidaskClub lowered Innospec from a “buy” rating to a “hold” rating in a research report on Thursday, September 26th. Finally, ValuEngine lowered Innospec from a “sell” rating to a “strong sell” rating in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of $90.67.

About Innospec

Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals worldwide. It operates through four segments: Fuel Specialties, Performance Chemicals, Oilfield Services, and Octane Additives. The Fuel Specialties segment offers a range of specialty chemical products used as additives in various fuels.

Featured Story: Book Value Per Share – BVPS

Want to see what other hedge funds are holding IOSP? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Innospec Inc. (NASDAQ:IOSP).

Institutional Ownership by Quarter for Innospec (NASDAQ:IOSP)

Receive News & Ratings for Innospec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec and related companies with MarketBeat.com's FREE daily email newsletter.